Metaglip is a combination oral medication used to treat type 2 diabetes. It contains the active ingredients glipizide and metformin, which work together to improve blood sugar control. Glipizide stimulates pancreatic beta cells to release insulin, thereby lowering glucose levels after meals. Metformin reduces hepatic glucose production and enhances insulin sensitivity in peripheral tissues. The combined effect results in decreased fasting and post-prandial blood glucose concentrations. Physiologically, the drug promotes glucose uptake by muscle and adipose tissue and suppresses excessive glucose release from the liver. By modulating these pathways, Metaglip helps maintain stable glycemic levels throughout the day.

Metaglip is an oral antidiabetic medication used for type 2 diabetes. It combines two active ingredients that work together to improve blood glucose control. The first component belongs to a class of drugs that enhances insulin sensitivity. The second component stimulates the pancreas to release more insulin after meals. By increasing insulin activity and secretion, Metaglip lowers blood sugar levels effectively. This dual mechanism helps maintain stable glucose concentrations throughout the day. The coordinated action supports the therapeutic role of Metaglip in managing diabetes.

Metaglip may cause gastrointestinal discomfort such as nausea or diarrhea. It can also lead to a metallic taste in the mouth. Some users experience dizziness or lightheadedness, especially when standing up quickly. Hypoglycemia, though less common, may occur if blood sugar drops unexpectedly. Elevated liver enzymes are occasionally reported during treatment. Headache and mild skin rash are additional frequently observed reactions.

Metaglip may cause nausea or stomach upset in some patients. It can lead to headaches or dizziness occasionally. Some users report a metallic taste after taking the medication. Low blood sugar can occur especially when combined with other glucose-lowering drugs. Swelling of the limbs is a possible side effect. Fatigue or weakness may be experienced by certain individuals. Skin rashes or itching sometimes appear during treatment. Rarely elevated liver enzymes are observed in blood tests.